CNR Institutional Research Information System

QUARANTELLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.729
NA - Nord America 1.770
EU - Europa 806
SA - Sud America 702
AF - Africa 58
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.668
SG - Singapore 1.633
CN - Cina 764
BR - Brasile 555
VN - Vietnam 388
HK - Hong Kong 387
FR - Francia 243
IT - Italia 205
JP - Giappone 142
KR - Corea 130
DE - Germania 65
IN - India 65
NL - Olanda 59
AR - Argentina 53
FI - Finlandia 52
BD - Bangladesh 51
GB - Regno Unito 50
CA - Canada 45
EC - Ecuador 30
MX - Messico 23
ID - Indonesia 21
TR - Turchia 21
ZA - Sudafrica 21
IL - Israele 19
IQ - Iraq 19
PL - Polonia 19
RU - Federazione Russa 16
CO - Colombia 15
AT - Austria 14
CL - Cile 13
PY - Paraguay 13
ES - Italia 12
SA - Arabia Saudita 12
MY - Malesia 10
SE - Svezia 10
UA - Ucraina 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 9
VE - Venezuela 9
UY - Uruguay 8
IE - Irlanda 7
JM - Giamaica 7
PK - Pakistan 7
TH - Thailandia 7
AL - Albania 6
MA - Marocco 6
NI - Nicaragua 6
UZ - Uzbekistan 6
AU - Australia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
EG - Egitto 4
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
AZ - Azerbaigian 3
CR - Costa Rica 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PA - Panama 3
SN - Senegal 3
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
NP - Nepal 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
IS - Islanda 1
KW - Kuwait 1
Totale 7.062
Salva come PNG Salva come JPEG
Città #
Singapore 1.022
Santa Clara 614
Hong Kong 385
Hefei 296
San Jose 198
Lauterbourg 190
Beijing 152
Ho Chi Minh City 140
Seoul 128
Ashburn 117
Tokyo 115
Hanoi 108
Los Angeles 84
New York 50
São Paulo 47
Helsinki 35
Naples 34
Guangzhou 27
Dallas 24
Afragola 22
Frankfurt am Main 21
Orem 20
Minamishinagawa 19
Haiphong 18
Council Bluffs 17
Rome 17
Bengaluru 15
Brasília 15
Rio de Janeiro 15
Milan 14
Warsaw 14
Montreal 13
Phoenix 13
Toronto 13
Johannesburg 12
Lappeenranta 12
Nuremberg 12
Buffalo 11
Da Nang 11
Quito 11
Belo Horizonte 9
Santo André 9
Shanghai 9
Stockholm 9
Casandrino 8
Curitiba 8
Düsseldorf 8
Mumbai 8
Porto Alegre 8
Salvador 8
Atlanta 7
Brooklyn 7
Can Tho 7
Kingston 7
Manchester 7
Montevideo 7
Portsmouth 7
Quận Bình Thạnh 7
Santiago 7
Vienna 7
Ankara 6
Bauru 6
Buenos Aires 6
Denver 6
Dubai 6
Dublin 6
Elk Grove Village 6
Falkenstein 6
Guayaquil 6
Houston 6
Hải Dương 6
Istanbul 6
Jakarta 6
Kyiv 6
London 6
Managua 6
Paris 6
Tashkent 6
Amsterdam 5
Biên Hòa 5
Boston 5
Casablanca 5
Chennai 5
Contagem 5
Goiânia 5
Guarujá 5
Guarulhos 5
Ha Long 5
Jacksonville 5
Jeddah 5
João Pessoa 5
Newark 5
Tirana 5
Turku 5
Almaty 4
Baghdad 4
Bangkok 4
Brisbane 4
Bắc Giang 4
Caraguatatuba 4
Totale 4.447
Salva come PNG Salva come JPEG
Nome #
DTI and attention function. Dose-response evaluation in partial brain irradiation 113
A polynomial regression-based approach to estimate relaxation rate maps suitable for multiparametric segmentation of clinical brain MRI studies in multiple sclerosis 94
Abnormal or delayed development of the posterior membranous area of the brain: anatomy, ultrasound diagnosis, natural history and outcome of Blake's pouch cyst in the fetus 88
Imaging of brain TSPO expression in a mouse model of stroke with [18F]DPA-714 and micro-PET 86
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 84
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 81
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 81
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [F-18]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis 78
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial 73
CYP7B1 screening in multiple sclerosis patients shows association among new variants, pyramidal signs and autoimmune disease 71
Flexibility of brain dynamics is increased and predicts clinical impairment in relapsing–remitting but not in secondary progressive multiple sclerosis 71
In vivo imaging and characterization of [F-18]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET 68
Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis 67
Imaging of Brain TSPO Expression in a Mouse Model of Amyotrophic Lateral Sclerosis with [18F]DPA-714 and Micro-PET/CT. 67
Estimating brain atrophy in clinical settings: linear measures of ventricular enlargement for evaluation of disease activity and long-term disability progression in Multiple Sclerosis 64
Biofeedback Rehabilitation in Patients with Stargardt disease: a randomized controlled trial 61
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin 61
Grey: white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression 60
Jugular foramen stenosis in external hydrocephalus in infants 55
Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study 55
Whole-Brain Propagation Delays in Multiple Sclerosis, a Combined Tractography-Magnetoencephalography Study 55
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon Beta-1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 54
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach 54
Brain alteration in a Nude/SCID fetus carrying FOXN1 homozygous mutation 53
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy 53
Multivariate Fuzzy Analysis of Brain Tissue Volumes and Relaxation Rates for Supporting the Diagnosis of Relapsing- Remitting Multiple Sclerosis 53
In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET 53
In vivo study of biodistribution and specific binding of [18 F] DPA-714, a traslocator protein-specific (TSPO) radioligand, in mice with microPET-CT. 53
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis 52
Dynamical interactions reconfigure the gradient of cortical timescales 52
In vivo biodistribution and specific binding of 18F-DPA-714, a Traslocator Protein-Specific (TSPO) radioligand, in mice with microPET-CT. 51
The structural connectome constrains fast brain dynamics 51
An MRI digital brain phantom for validation of segmentation methods 51
StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions 51
Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study) 50
Correction to: Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin (European Radiology, (2022), 33, 3, (2185-2194), 10.1007/s00330-022-09154-y) 50
Biofeedback Rehabilitation and Visual Cortex Response in Stargardt's Disease: A Randomized Controlled Trial 48
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 48
A Voxel-Based Approach to Explore Local Dose Differences Associated With Radiation-Induced Lung Damage 47
Magnetic resonance parkinsonism indices and interpeduncular angle in idiopathic normal pressure hydrocephalus and progressive supranuclear palsy 47
Reduced Striatal DAT Uptake Normalizes After Shunt in Normal-Pressure Hydrocephalus 46
Multimodal mri assessment of thalamic structural changes in earthquake survivors 45
SPG5 and multiple sclerosis: Clinical and genetic overlap? 44
Current status and future prospective of neuroimaging for epilepsy 44
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panel 44
A combined radiomics and machine learning approach to overcome the clinicoradiologic paradox in multiple sclerosis 43
Unraveling deep gray matter atrophy and iron and myelin changes in multiple sclerosis 43
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment 43
Searching for the grail: may machine learning be a road to clinical use of brain MRI segmentation? 43
Fully automated measurement of intracranial CSF and brain parenchyma volumes in pediatric hydrocephalus by segmentation of clinical MRI studies 43
Imaging of brain TSPO expression with [18F]DPA-714 PET/CT and immunofluorescence analysis in mouse model of ALS. 42
Frequency encoding for simultaneous display of multimodality images 42
Default-Mode Network Connectivity Changes Correlate with Attention Deficits in ALL Long-Term Survivors Treated with Radio-and/or Chemotherapy 42
Feasibility of tract based dosimetric analysis in brain tumor patients 41
Regional Dose Differences Associated with Radiation-Induced Acute Severe Dysphagia 41
Changes in venous drainage after posterior cranial vault distraction and foramen magnum decompression in syndromic craniosynostosis 41
Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson's Disease 41
Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes 40
Extra-osseous Tc-99m methylene diphosphonate uptake detected enlargement of the knee joint in patient with polyarthritis 40
Voxel Based Analysis of Dose Maps: Are We Addressing the Right Strategy? 40
Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms. 39
SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment 39
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 39
Integrated software for the analysis of brain PET/SPECT studies with Partial Volume Effect Correction 38
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results 38
Pro-inflammatory biomarkers predictive of poor response to Interferon beta1a in multiple sclerosis 37
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation 37
Modifications of brain tissue volumes in facioscapulohumeral dystrophy 37
Accuracy of neurosonography and MRI in clinical management of fetuses referred with central nervous system abnormalities 36
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis 35
Is advanced neuroimaging for neuroradiologists? A systematic review of the scientific literature of the last decade 35
Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes 35
Assessment of scanner performance and normalization of estimated relaxation rate values 35
Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity 35
Visual Cortex Activation in Patients With Stargardt Disease 35
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 35
Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-betA (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study, Lyon. France 34
Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach 34
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 33
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. 33
Grey/white matter ratio at diagnosis, and the risk of 10-year multiple sclerosis progression 33
Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. 32
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study 32
Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies 32
Generalized formalism of the Extended Phase Diagram and computational applications including an MRI simulator 32
Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis 32
Large infratentorial subdural hemorrhage diagnosed by ultrasound and MRI in a second-trimester fetus 31
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington's disease 31
Brain Morphometry Correlates of Pharmacoresistancy in Schizophrenia 31
Pragmatic abilities in multiple sclerosis: An rs-fMRI study 31
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice 31
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 30
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel - based morphometry study 30
Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study 30
Looking for the best therapeutical strategy after the 24th natalizumab administration. The TY-STOP study 29
Complex phenotype in an Italian family with a novel mutation in SPG3A 29
Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and nondeficit schizophrenia. 29
Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: A PET/MR hybrid scanner study 29
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. 29
SPECT study of GABAA/BZD receptors and cerebral blood flow in mild cognitive imparment (MCI) 29
Totale 4.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.420
article - articoli 22.945
book - libri 273
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.638
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202441 0 0 0 0 0 0 0 0 2 0 34 5
2024/20252.732 21 11 287 141 599 69 27 64 98 110 681 624
2025/20264.404 216 449 409 590 831 192 668 210 326 297 216 0
Totale 7.177